Sept 15 (Reuters) - Cyclopharm Ltd (CYC) :
- TECHNEGAS PHASE 3 TRIAL IN US MET PRIMARY EFFICACY ENDPOINT
- TECHNEGAS COMMERCIAL SALES EXPECTED IN UNITED STATES IN 2021
News: CYC Cyclopharm Says Technegas Phase 3 Trial In U.S. Met Primary Efficacy Endpoint
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.02 |
Change
0.020(2.01%) |
Mkt cap ! $112.8M | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.04 | $1.00 | $66.88K | 65.41K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 13957 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 14656 | 2 |
View Market Depth
| Last trade - 12.08pm 17/06/2025 (20 minute delay) ? |
| CYC (ASX) Chart |